Larvol Delta - Bright-Minds-Biosciences-Initiates-Dosing-in-Phase-I-Clinical-Trial-of-BMB101-for-Dravet-Syndrome

BMB-101 - Bright Minds

https://www.globenewswire.com/news-release/2022/08/31/2507460/0/en/Bright-Minds-Biosciences-Initiates-Dosing-in-Phase-I-Clinical-Trial-of-BMB-101-for-Dravet-Syndrome.html

Aug 31, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next